Morningstar

Johnson & Johnson Announces FDA Approval of TECNIS PureSee Intraocular Lens, a Breakthrough Solution for U.S. Cataract Patients

Johnson & Johnson (NYSE: JNJ) announced U.S. Food and Drug Administration (FDA) approval of TECNIS PureSee IOL, an extended depth of focus (EDOF) intraocular lens (IOL) intended for use in cataract ...
Seeking Alpha

J&J wins FDA nod for Tecnis PureSee intraocular lens

Johnson & Johnson (JNJ) announced on Thursday that the U.S. Food and Drug Administration (FDA) approved its Tecnis PureSee intraocular lens (IOL), giving eye surgeons a new lens option for use in ...
Detroit Free Press

Dr. Steven J. Dell of Dell Laser Consultants Among the First Surgeons in the U.S. to Implant the New TECNIS PureSee™ IOL

AUSTIN, TX, UNITED STATES, April 2, 2026 /EINPresswire.com/ — Dell Laser Consultants is proud to be among the first practices in the United States to offer the ...